Is one vaccine dose enough if you’ve had Covid? What the science says
nature.com
nature.com
This is one thing that’s been incredibly frustrating throughout this whole pandemic. Studies and research will show B, with no sign of A, however inertia/politics/fear/ignorance will continue to push A to the point of harm.
An example - a local store was insisting on wiping down the entire checkout conveyor with alcohol between every single customer until very recently, when we’ve know for a long time that you won’t get COVID from that.
It’s about feeling safe, not about being safe.
As someone from a country where running orders are still to disinfect often-touched surfaces (switches, door handles, office desks, etc.) I was surprised by this.
I went to check what CDC from US recommends. It turns out it's pretty much the same:
> Clean high touch surfaces daily. This includes tables, doorknobs, light switches, countertops, handles, desks, phones, keyboards, toilets, faucets, and sinks.
(from https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-si...)
So maybe wiping down the belt between every customer is a bit excessive, but it seems my sources don't agree with the "you don't get COVID from that" part.
Cleaning for an airborne illness is just theater. Upgrading air handlers, increasing airflow, and spacing people further apart matter. Cleaning stuff randomly just makes people feel better (but can make good business sense because of this!)
But it's really hard to stop it when the mantra is "Better safe than sorry".
As vaccines grow in numbers and we have solid information like the one linked here, i have faith that we can return to doing things we know work.
A checkout belt isn't even close to a 'high-touch' surface - I don't think I've ever touched one, and neither do the checkers. And the difference between 'daily' and 4-500x daily is dramatic.
At least for France, their Infectious Disease professionals go further. They're of the opinion that a second dose in someone that's been infected (within a certain range of time) is subjecting them to unnecessary treatment, wasted time and side effects for no/limited benefit.
It's not to make the most of limited supplies.
Auto-translation (with some readability tweaks):
> If the second dose of vaccine has already been administered to people with a history of infection with SARS-Cov-2, the data available to date do not show any difference in the safety profile apart from the occurrence of more common systemic reactions.
https://www.has-sante.fr/jcms/p_3237271/en/strategie-de-vacc...
But questioning the value of a vaccine under any circumstances is ban-worthy in a lot of places.
As I understand the variants are not like the flu or the cold (yet!)
If antibodies fall off quickly from an actual infection, why would this not also happen for the antibodies produced because of taking the vaccine?
I’d be curious if currently available vaccines stimulate such preexisting antibody-producing bone marrow cells of past COVID patients (which sounds more optimal on the face of it), or they trigger yet another variety of antibodies to be produced in addition to the “native” one.
[0] https://www.nature.com/articles/d41586-021-01442-9#ref-CR1 “Had COVID? You’ll probably make antibodies for a lifetime”
We just haven't had enough time to prove it yet, or to investigate the differences between variants.
Also note that vaccines focus on the Spike protein only, and you're immunesystem takes the entire virus into account, which might offer better protection against variants.
https://www.medrxiv.org/content/10.1101/2021.06.01.21258176v...
https://www.gov.uk/government/news/past-covid-19-infection-p...
>>PHE scientists working on the study have concluded naturally acquired immunity as a result of past infections provide 83% protection against reinfection, compared to people who have not had the disease before. This appears to last at least for 5 months from first becoming sick.
any data on second shots for folks who took the J&J?
Like Sputnik V, J&J's Janssen unit's Ebola vaccine uses two different virus vectors. And Janssen is doing an ENSEMBLE 2 Phase III clinical trial with two doses eight weeks apart that lol768 mentions. But their primary objective stated from the very beginning was to create the most effective single dose vaccine possible, and vaccinated a billion people in 2021.
They appear to have achieved the former, although Sputnik Lite with the same Ad26 based vector could be a competitor, the latter goal is failing due to inherent issues with using cell culturing to make something, a strained supply chain for that which is also required to make Oxford's Sputnik V, and Novavax's vaccine (bug cell grown protein plus adjuvant), and being forced to use the dangerously incompetent Emergent BioSolutions as a subcontractor.
Emergent BioSolutions was contamination between the J&J side of production with the Oxford/AstraZeneca vaccine side of production...
What is the preferred sample size to back these sorts of claims?
I often hear from people that recovered from Covid that they don't need the vaccine, Rand Paul is one notable example, due to their natural antibodies.
I'm curious to know what the average antibody titer level of previously infected people is to start. Or how much more protection do they get once vaccinated?
As someone who's only got one dose so far, I would gladly skip the second one if I knew for certain I had COVID before, so someone else could get my second dose.
We would need some form of official recognition of antibody tests though. Pretty sure most places that require vaccination don't accept antibody test results.
In NYC, for example, they've been available for free at a ton of different sites. It may always be as convenient or quick, but it's free.
The half-life of antibody levels has been estimated at 73 days. The antibody tests are quite sensitive, time has not been enough of a factor yet to produce false negatives. In a year or two it might be.
The only time concern is that you need to wait 2-3 weeks until after you recover from COVID to ensure you test positive.
See the section called "Binding Antibody Tests" here:
https://creakyjoints.org/living-with-arthritis/coronavirus/c...
First paragraph of the article: “Many people who’ve been infected with the coronavirus might be able to safely skip the second jab of any two-dose vaccine regimen, a growing number of studies suggest. These results could help to stretch scarce vaccine supplies and are already influencing vaccination policies in some countries.”
US might have enough for everyone, and wouldn’t it be also great if we didn’t need as many doses and could share with hard hit places like India? I see this as a net positive if true.
Lots of doses are going to get tossed. Most the people who are going to get the shot have gotten it already.